Overview

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Status:
Not yet recruiting
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal pulmonary artery thrombus and right ventricular dilation.
Phase:
Phase 3
Details
Lead Sponsor:
NYU Langone Health
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Anticoagulants